This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Myrexis, Inc.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Matthew Reeder: Innovator in Therapeutic Compounds
Introduction
Matthew Reeder is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of therapeutics, particularly in the development of compounds that target abnormal cell growth. His work is essential in addressing various clinical conditions that require innovative solutions.
Latest Patents
Matthew Reeder holds 1 patent for his invention titled "Compounds and therapeutical use thereof." This patent discloses 4-arylamino-quinazolines and their analogs, which are effective as activators of caspases and inducers of apoptosis. The compounds developed through this invention are useful in treating a variety of clinical conditions characterized by uncontrolled growth and spread of abnormal cells.
Career Highlights
Matthew Reeder is associated with Myrexis, Inc., where he applies his expertise in therapeutic development. His work at the company has been instrumental in advancing research and innovation in the field of medicine.
Collaborations
Some of his notable coworkers include Mark B Anderson and J Adam Willardsen. Their collaboration contributes to the innovative environment at Myrexis, Inc., fostering advancements in therapeutic research.
Conclusion
Matthew Reeder's contributions to the field of therapeutics through his innovative compounds highlight the importance of research in combating abnormal cell growth. His work continues to pave the way for new treatments and solutions in medicine.